Evidence map›Paper›PMID 40991327›Full record

ArticleBriefings in bioinformatics2025

Growing and linking optimizers: synthesis-driven molecule design.

Clarisse Descamps, Vincent Bouttier, Juan Sanz García, Maoussi Lhuillier-Akakpo, Quentin Perron, Hamza Tajmouati

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Clarisse DescampsIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.
Vincent BouttierIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.
Juan Sanz GarcíaIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.
Maoussi Lhuillier-AkakpoIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.
Quentin PerronIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.
Hamza TajmouatiIktos, 65 Rue de Prony, 75017 Paris, Île-de-France, France.

Funding

Iktos
6 · The paper itself

Abstract

In the present work, two reaction-based generative models for molecular design are presented: growing optimizer and linking optimizer. These models are designed to emulate real-life chemical synthesis by sequentially selecting building blocks and simulating the reactions between them to form new compounds. By focusing on the feasibility of the generated molecules, growing optimizer and linking optimizer offer several advantages, including the ability to restrict chemistry to specific building blocks, reaction types, and synthesis pathways, a crucial requirement in drug design. Unlike text-based models, which construct molecules by iteratively forming a textual representation of the molecular structure, and graph-based models, which assemble molecules atom by atom or fragment by fragment, our approach incorporates a more comprehensive understanding of chemical knowledge, making it relevant for drug discovery projects. Comparative analysis with REINVENT 4, a state-of-the-art molecular generative model, shows that growing optimizer and linking optimizer are more likely to produce synthetically accessible molecules while reaching molecules of interest with the desired properties.

Indexed as

Drug DesignDrug DiscoveryAlgorithmsModels, Moleculardeep learningdrug designgenerative AIhit discoverylead optimizationreinforcement fine tuning

Identifiers

PMID40991327
PMCPMC12459256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.